High-pressure inclusion body solubilization and protease clipping of recombinant fusion proteins
View Patent ↗Described herein are methods for the solubilization and proteolytic cleavage of fusion protein aggregates, including autocatalytic fusion proteins, at pressures greater than atmospheric pressure to yield soluble target polypeptides.
1. A method for producing soluble target polypeptide in samples comprising fusion protein aggregates comprising the steps of:
a) subjecting a mixture comprising an aqueous solution and/or aqueous suspension comprising protease and fusion protein aggregates to increased hydrostatic pressure compared to atmospheric pressure for a time sufficient for formation of soluble target polypeptide; and,
b) decreasing the pressure to atmospheric pressure,
wherein said target polypeptides are produced by specific proteolytic cleavage of said target polypeptides from the fusion protein and a portion of the target polypeptide is soluble at atmospheric pressure.
2. The method of claim 1 , further comprising a step (c) comprising:
c) purifying the target polypeptide obtained in step (b).
3. The method of claim 1 , wherein in step (a), the increased hydrostatic pressure is from about 500 to about 10000 bar.
4. The method of claim 1 , wherein step (b) comprises stepwise pressure reductions.
5. The method of claim 1 , wherein step (b) comprises a continuous rate of pressure reduction.
6. The method of claim 1 , wherein the pH of the mixture is from about pH 4 to about pH 12.
7. The method of claim 1 , wherein step (a) is performed at a temperature from about 0° C. to about 100° C.
8. The method of claim 1 , wherein the mixture further comprises a reducing agent.
9. The method of claim 1 , wherein the method further comprises addition of a target polypeptide ligand binding partner.
10. The method of claim 1 , wherein the mixture further comprises a cleavage buffer.
11. The method of claim 10 , wherein the cleavage buffer further comprises one or more additional agents selected from the group consisting of one or more stabilizing agents, one or more buffering agents, one or more surfactants, one or more disulfide shuffling agent pairs, one or more chaotropic agents, one or more salts, and combinations of two or more of the foregoing.
12. The method of claim 11 , wherein the one or more additional agents is one or more stabilizing agents.
13. The method of claim 11 , wherein the one or more additional agents is one or more surfactants.
14. The method of claim 11 , wherein the one or more additional agents is one or more buffering agents.
15. The method of claim 11 , wherein the one or more additional agent is one or more chaotropic agents.
16. The method of claim 11 , wherein the one or more additional agents are one or more disulfide shuffling agent pair.
17. The method of claim 1 , wherein the time in step (a) is from about 15 minutes to about 50 hours.
18. The method of claim 1 , wherein the fusion partner is selected from the group consisting of his-tags, maltose-binding protein, thioredoxin, glutathione-s-transferase, DsbA, gphD, FLAG, calmodulin binding protein, streptag II, HA-tag, Softag1, Softag 3, c-myc, T7-tag, S-tag, NusA, chitin-binding domain, xylanase 10A, tobacco etch virus, and ubiquitin.
19. The method of claim 1 , wherein the protease is a serine, cysteine or metalloprotease.
20. The method of claim 1 , wherein the fusion protein comprises the protease.
21. The method of claim 1 , wherein the total concentration of fusion protein in the fusion protein aggregate is from about 0.01 mg/mL to about 500 mg/mL.
22. The method of claim 1 , wherein step (a) further comprises agitation of the mixture.
23. The method of claim 1 , wherein the method does not include one or more chaotropic agents.
24. The method of claim 1 , further comprising performing solution exchange.